$AXXE News - Axxess Pharma, Inc. Hires Legal and Sales Veteran Michael Gelmon to Assist in Business Development and SEC Compliance

Mr. Gelmon Was Prior Founder and CEO of Company Generating Over $300 Million in Sales - TORONTO, ON - (http://www.financialnewsmedia.com News Alert) - Axxess Pharma Inc. (OTC: AXXE), a company that develops a variety of nutritional supplements and specialty pharmaceutical products through its subsidiary company AllStar Health Brands Inc., is pleased to announce they have hired Michael Gelmon B.A., LL.B., a top tier legal and sales veteran to assist in business development and SEC compliance. Mr. Gelmon, who has been retained as a consultant, also brings forth strong experience successfully founding and managing public companies. Mr. Gelmon\'s prior start-up company generated over $300 million in sales.



The hiring of Mr. Gelmon comes at a time when Axxess Pharma is preparing for strong global sales in the second half of 2015. Sales will be partially fueled by the recent developments listed below:



1) Signing of a major manufacturing, marketing and distribution agreement with Chinese manufacturer. Axxess Pharma projects minimum sales of $525,000 USD in the first year and $4,308,000 USD in the initial 5 year term of the license. Sales are projected to start in third quarter of 2015.



2) Contract with Canada\'s leading health product franchise \"Nutrition House\" to sell the full line of Tapout products in over 60 high profile shopping centers across Canada by early summer.



3) Axxess Pharma currently in final preparations with large supermarket chain to have Tapout products on shelves of supermarkets- nationwide.



4) Major Canadian distributor signs contract to sell Muscle Spray and Tapout Pain relief Towelettes to over 2,000 independent pharmacies across Canada. This represents approximately ten percent of all Canadian pharmacies.



5) Management submitting financial audits to FINRA within 3 weeks for immediate up-listing to OTCQB.



Mr. Gelmon stated: \"This is an exciting time for Axxess Pharma. They are on the verge of generating millions in annual sales due to their domestic and international agreements, expanded all-natural Tapout product lines and near-term up-listing to the more liquid OTCQB stock exchange.\" Mr. Gelmon further stated: \"I am very familiar with the challenges they will face ahead and will...